- Advertisement -

Months after cancer drug trial, Merus agrees to be bought at 41% premium

Must read




Merus agreed to be bought for a 41% premium, months after a positive trial of a cancer drug.



Source link

- Advertisement -

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisement -

Latest article